RESAMIRIGENE BILPARVOVEC
UNII F6LOJ6ER4S

Substance Identification & Data

This profile provides standardized clinical and technical data for Resamirigene Bilparvovec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F6LOJ6ER4S.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2085240-27-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

F6LOJ6ER4S

CAS Registry Number

2085240-27-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RESAMIRIGENE BILPARVOVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C177083

National Cancer Institute reference terminology for clinical and research data.

INN ID

10920

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-155

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Resamirigene Bilparvovec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RESAMIRIGENE BILPARVOVEC

Common Names & Synonyms

RESAMIRIGENE BILPARVOVEC [INN]

RESAMIRIGENE BILPARVOVEC [USAN]

Systematic Nomenclature

A RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE 8 (AAV8) VECTOR EXPRESSING HUMAN MYOTUBULARIN 1 (MTM1), UNDER THE CONTROL OF THE HUMAN DESMIN GENE PROMOTER

SYS